DrugsControl Media Services

News Detail

NPPA approves 157 intimations for discontinuation of scheduled formulations (11-08-2023)

New Delhi, 11 Aug 2023: The National Pharmaceutical Pricing Authority (NPPA) has received a total of 226 intimations under Form IV for discontinuation of scheduled formulations from the market between April 1, 2020 and July 31, 2023 and has approved 157 cases.

View Details

Source : Pharmabiz
National Pharmaceutical Pricing Authority NPPA Form IV Lok Sabha DPCO 2013 Schedule-II Baxter Pharmaceuticals Sedoz midazolam Sucrofer iron sucrose Zepita piperacillin tazobactam Zepita Panisa pantoprazole Profol propofol Pfizer Cyklokapron

Related News